Summary & Overview
CPT 3775F: Colonoscopy Screening with Adenoma or Neoplasm Documented
CPT code 3775F identifies a colonoscopic screening in patients aged 50 or older with documentation of one or more adenomas or other colonic neoplasms. This code is used to capture the presence of polyps or neoplastic findings identified during screening colonoscopy, which has implications for surveillance intervals, quality measurement, and population colorectal cancer prevention efforts nationwide. Payers commonly referenced in analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise clinical and billing context for CPT code 3775F, including its role in colorectal cancer screening workflows, the typical service setting (endoscopy suites or ambulatory surgical centers), common modifiers associated with the service, and how the code is used in quality measurement and reporting. The publication also covers payer coverage patterns and benchmarks where available, relevant policy updates affecting screening and surveillance, and practical considerations that influence coding and documentation. Data not available in the input is noted where applicable, and the content is presented for a national audience concerned with clinical documentation, billing accuracy, and program-level reporting.
Billing Code Overview
CPT code 3775F documents that a provider screens the colon of a patient aged 50 or older using a colonoscope, a flexible tube with a camera at one end, and records the presence of one or more adenomas or other neoplasm types.
-
Service type: Colonoscopic screening with documented adenoma or neoplasm
-
Typical site of service: Endoscopy suite or ambulatory surgical center where colonoscopy procedures are performed
Clinical & Coding Specifications
Clinical Context
A typical patient is a 60-year-old asymptomatic adult presenting for routine colorectal cancer screening. The patient has no acute complaints, multiple comorbidities under management, and has met the age threshold for screening. The clinical workflow includes pre-procedure evaluation and consent, bowel preparation instructions completed at home, verification of medication and anticoagulation status on arrival, sedation administered by an anesthetist or proceduralist, and colonoscopic visualization of the entire colon using a flexible colonoscope. During the exam the provider documents one or more adenomas or other neoplastic lesions by size, number, morphology, and location, with biopsy or removal performed as indicated. Post-procedure recovery includes monitoring until sedation effects resolve, discharge instructions, and documentation of pathology follow-up and surveillance interval planning when neoplasia is identified.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
52 | Reduced services | Use when the colonoscopy is performed but the service is partially reduced (for example, aborted due to poor prep but some diagnostic exam completed). |
53 | Discontinued procedure |